Elanco Animal Health (ELAN) Accumulated Expenses (2017 - 2025)
Elanco Animal Health's (ELAN) quarterly Accumulated Expenses came in at $206.0 million in Q4 2025, up 16.38% year-over-year from $177.0 million in Q4 2024, and up 16.38% quarter-over-quarter from $177.0 million in Q4 2024.
Analysis
Elanco Animal Health (ELAN) Accumulated Expenses (2017 - 2025) Analysis & Trends
Elanco Animal Health has disclosed Accumulated Expenses across 9 years of filings, most recently posting $206.0 million for Q4 2025.
- In Q4 2025, Accumulated Expenses rose 16.38% year-over-year to $206.0 million; the TTM figure through Dec 2025 stood at $206.0 million (up 16.38% YoY), while the FY2025 annual figure was $206.0 million, up 16.38% from the prior year.
- Accumulated Expenses came in at $206.0 million for Q4 2025 at Elanco Animal Health, up from $177.0 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $206.0 million in Q4 2025 to a low of $110.0 million in Q1 2023.
- Average Accumulated Expenses over 5 years is $144.8 million, with a median of $141.0 million recorded in 2022.
- Year-over-year, Accumulated Expenses surged 116.78% in 2021 and slipped 21.08% in 2022.
- Over 5 years, Accumulated Expenses stood at $185.0 million in 2021, then retreated by 21.08% to $146.0 million in 2022, then advanced by 7.53% to $157.0 million in 2023, then climbed by 12.74% to $177.0 million in 2024, then climbed by 16.38% to $206.0 million in 2025.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $206.0 million in Q4 2025, $177.0 million in Q4 2024, and $157.0 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.52 Bn | 40.33 Bn | 779.09 Mn |
| 2 | Zoetis | 30.69 Bn | 29.02 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 206.00 Mn |
| Dec 31, 2024 | 177.00 Mn |
| Dec 31, 2023 | 157.00 Mn |
| Mar 31, 2023 | 110.00 Mn |
| Dec 31, 2022 | 146.00 Mn |
| Sep 30, 2022 | 136.00 Mn |
| Jun 30, 2022 | 113.00 Mn |
| Mar 31, 2022 | 111.00 Mn |
| Dec 31, 2021 | 185.00 Mn |
| Sep 30, 2021 | 159.00 Mn |
| Jun 30, 2021 | 124.00 Mn |
| Mar 31, 2021 | 114.00 Mn |
| Dec 31, 2020 | 144.00 Mn |
| Sep 30, 2020 | 139.90 Mn |
| Jun 30, 2020 | 57.20 Mn |
| Mar 31, 2020 | 56.20 Mn |
| Dec 31, 2019 | 99.60 Mn |
| Sep 30, 2019 | 88.80 Mn |
| Jun 30, 2019 | 67.30 Mn |
| Mar 31, 2019 | 64.20 Mn |